BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32871218)

  • 1. Development of an amphotericin B micellar formulation using cholesterol-conjugated styrene-maleic acid copolymer for enhancement of blood circulation and antifungal selectivity.
    Banshoya K; Kaneo Y; Tanaka T; Yamamoto S; Maeda H
    Int J Pharm; 2020 Nov; 589():119813. PubMed ID: 32871218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of styrene-maleic acid copolymer conjugated amphotericin B.
    Banshoya K; Kaneo Y; Tanaka T; Yamamoto S; Maeda H
    Int J Pharm; 2019 Dec; 572():118719. PubMed ID: 31654700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
    Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
    Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.
    Han K; Miah MA; Shanmugam S; Yong CS; Choi HG; Kim JA; Yoo BK
    Arch Pharm Res; 2007 Oct; 30(10):1344-9. PubMed ID: 18038914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin B.
    Diezi TA; Kwon G
    Pharm Res; 2012 Jul; 29(7):1737-44. PubMed ID: 22130733
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Liu F; Yang L; Li Y; Junier A; Ma F; Chen J; Han H; Glass Z; Zhao X; Kumamoto CA; Sang H; Xu Q
    ACS Biomater Sci Eng; 2020 Feb; 6(2):1064-1073. PubMed ID: 33464849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles.
    Yu BG; Okano T; Kataoka K; Sardari S; Kwon GS
    J Control Release; 1998 Dec; 56(1-3):285-91. PubMed ID: 9801451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B.
    Serafim C; Ferreira I; Rijo P; Pinheiro L; Faustino C; Calado A; Garcia-Rio L
    Int J Pharm; 2016 Jan; 497(1-2):23-35. PubMed ID: 26617315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
    Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
    Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
    Greish K; Nagamitsu A; Fang J; Maeda H
    Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections.
    Moreno-Rodríguez AC; Torrado-Durán S; Molero G; García-Rodríguez JJ; Torrado-Santiago S
    Int J Pharm; 2015 Oct; 494(1):17-22. PubMed ID: 26256151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphiphilic hyperbranched polyglycerol nanoarchitectures for Amphotericin B delivery in Candida infections.
    Jafari M; Abolmaali SS; Borandeh S; Najafi H; Zareshahrabadi Z; Heidari R; Azarpira N; Zomorodian K; Tamaddon AM
    Biomater Adv; 2022 Aug; 139():212996. PubMed ID: 35891600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
    Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
    J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat.
    Dangi JS; Vyas SP; Dixit VK
    Drug Dev Ind Pharm; 1998 Jul; 24(7):631-5. PubMed ID: 9876507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.
    Tsukigawa K; Liao L; Nakamura H; Fang J; Greish K; Otagiri M; Maeda H
    Cancer Sci; 2015 Mar; 106(3):270-8. PubMed ID: 25529761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of GM1 micelles-Amphotericin B interaction.
    Leonhard V; Alasino RV; Bianco ID; Garro AG; Heredia V; Beltramo DM
    Curr Drug Deliv; 2015; 12(4):406-14. PubMed ID: 25772153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B.
    Song Z; Wen Y; Deng P; Teng F; Zhou F; Xu H; Feng S; Zhu L; Feng R
    Carbohydr Polym; 2019 Feb; 205():571-580. PubMed ID: 30446143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B.
    Yu BG; Okano T; Kataoka K; Kwon G
    J Control Release; 1998 Apr; 53(1-3):131-6. PubMed ID: 9741920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.
    Nimtrakul P; Tiyaboonchai W; Lamlertthon S
    Curr Drug Deliv; 2019; 16(7):645-653. PubMed ID: 31362675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.